Venous Thromboembolism Clinical Trials in Boston, Massachusetts

5 studies are recruiting for venous thromboembolism in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Computerized Registry of Patients With Venous Thromboembolism (RIETE)

   The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet t…

   Stage

   Not phased

   Ages

   Any age

   Site

   Massachusetts General Hospital, Boston, Massachusetts

   Locations

   297 in total

   Run by

   Manuel Monreal

   See if you can join NCT02832245 on ClinicalTrials.gov

2. Statins to Prevent Cancer Associated Blood Clots

   Patients with cancer are at high risk for life-threatening venous thromboembolism (VTE) yet rarely receive anticoagulant prophylaxis due to bleeding risks. Thus, effective prophylaxis in oncology requires a method to reduce VTE without increasing hemorrhage. The primary aim of the Statin Therapy to…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   Beth Isreal Deaconess Medical Center, Boston, Massachusetts

   Locations

   9 in total

   Run by

   Brigham and Women's Hospital

   See if you can join NCT07303816 on ClinicalTrials.gov

3. Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)

   Hospitalized medical patients have an increased risk of venous thromboembolism (VTE) across the continuum of care, including after hospital discharge. In the APEX Trial of hospitalized patients with acute medical illness, extended-duration post-discharge thromboprophylaxis with oral betrixaban redu…

   Stage

   Not phased

   Ages

   40 and older

   Site

   Brigham and Women's Hospital, Boston, Massachusetts

   Run by

   Brigham and Women's Hospital

   See if you can join NCT03728166 on ClinicalTrials.gov

4. The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

   The aim of this Phase 3 study is to evaluate the efficacy of Kinisoquin™ as compared to the placebo in prevention of thromboembolic events in patients with metastatic or locally advanced pancreatic cancer.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Beth Israel Deaconess Medical Center, Boston, Massachusetts

   Locations

   3 in total

   Run by

   Quercis Pharma AG

   See if you can join NCT06861088 on ClinicalTrials.gov

5. Supplemental Oxygen in Pulmonary Embolism (SO-PE)

   A study of how supplemental oxygen helps patients with acute pulmonary embolism (PE). Hypothesis: Oxygen affects right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (PE) primarily by relieving hypoxic pulmonary vasoconstriction and reducing pulmonary pressure (PA) pressure…

   Stage

   EARLY_Phase 1

   Ages

   18 and older

   Site

   Massachusetts General Hospital, Boston, Massachusetts

   Run by

   Massachusetts General Hospital

   See if you can join NCT05891886 on ClinicalTrials.gov